VANCOUVER, Feb. 6, 2019 /PRNewswire/ - Nova-BioRubber announced today it had completed hypoallergenicity tests of their sustainably produced "biolatex" with excellent results. The third party testing agency – Akron Rubber Development Lab – issued official test results for two biolatex samples demonstrating antigenic protein content below detection. This is significant as it provides product manufacturers the ability to deliver hypoallergenic and sustainable latex/rubber products. Currently, latex allergies are widespread, with 6.4% of the general population suffering from allergic reactions to latex products. Biolatex, produced from annual rubber plant Taraxacum kok-saghyz (TKS) in British Columbia, Canada, can address the latex allergy challenge. TKS takes only 4 months to grow and contains up to 24% rubber and 40% inulin.
Dr. Jeff Martin, President/CEO of Yulex Corporation agrees. "These are excellent results and quite encouraging. Developments like these are in complete alignment with Yulex's vision of protecting and improving the health of people and the planet by replacing petroleum-based and toxic materials with safe, plant-based specialty natural rubber and energy."
"It's great to get these results," said Dr. Anvar Buranov, CEO of Nova-BioRubber. "Many products, and the way they are produced, are going to significantly change. We're going to see many more non-allergenic and non-odorous biolatex and biorubber products introduced to the market, including critical medical products like gloves and catheters, as well as other products like latex mattresses, pillows, yoga mats, condoms, wetsuits, swim caps, balloons, and much, much more."
Dr. Buranov continues, "We're particularly proud of our sustainable methods of production. We extract our biorubber, biolatex and inulin from the annual rubber plant TKS using a patented green process that is a unique combination of mechanical forces in a dry medium, resulting in energy savings, labour costs, and reduced water consumption. The process also has no chemical emissions."
Nova-BioRubber is committed to establishing a biorubber industry in North America and is seeking industrial partners, investors, and farmers to explore this massive market potential. Market value for biorubber and biolatex are anticipated to be around $200 billion due to hypoallergenic properties.
Third party evaluation reports and testing results from both Akron Rubber Development Lab and the National Research Council of Canada are available on request.
CONTACT: Media Contact: Dr. Anvar Buranov, Nova-BioRubber Green Technologies Inc, phone # 778-554-9459, Email: firstname.lastname@example.org, Website: www.novabiorubber.net